Diebold Nixdorf, Incorporated (DBD)
Valuation Overview•Is Diebold Nixdorf, Incorporated Overvalued or Undervalued?
Trading at a discount across both intrinsic cash flow and relative peer multiples, indicating a strong margin of safety.
Moderate quality score of 46/100, reflecting stable operating margins and manageable leverage.
Analysts remain bullish, forecasting further upside expansion with consensus targets suggesting solid gains.
Verdict: Average quality business weighed down by significant profitability concerns.
Wall Street is highly bullish, projecting significant upside alongside robust expected earnings growth. This is paired with healthy capital returns, driven predominantly by aggressive share repurchases.
Returns capital exclusively via buybacks — no active dividend
DBD struggles with subpar profitability and pressured margins. This is paired with a moderately leveraged but stable balance sheet.
The company exhibits steady, low-single-digit revenue growth paired with stable bottom-line earnings. Operating efficiency remains adequate with margins around 8.0%.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $891.8M | +1.5% | +3.2% | -0.5% | +4.6% | |
| EBITDA | $32.7M | — | — | — | — | |
| Net Income | $6.7M | +673.3% | — | — | +2.1% | |
| EPS (Diluted) | $0.14 | +677.3% | — | — | +8.5% | |
| Free Cash Flow | $26.1M | +99.8% | — | — | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 26.0% | 24.7% | 24.6% | 23.8% |
| Operating Margin | 8.0% | 5.3% | 2.7% | 1.6% |
| Net Margin | 2.8% | 12.9% | 4.0% | -1.8% |
| FCF Margin | 6.9% | 1.0% | -1.6% | -1.3% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.61 | $0.60 | -1.6% | ||
| Q1'26 | $1.61 | $3.02 | +87.6% | ||
| Q4'25 | $0.66 | $1.39 | +110.6% | ||
| Q3'25 | $0.61 | $0.60 | -1.6% | ||
| Q2'25 | $0.55 | $0.07 | -87.3% | ||
| Q1'25 | $1.05 | $0.97 | -7.6% | ||
| Q4'24 | $1.36 | $0.53 | -61.0% | ||
| Q3'24 | $1.11 | $1.16 | +4.5% |
Total return is +61.8% (1Y), outperforming the benchmark by +36.8%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +31.0% | +21.7% | — |
| 1Y | +61.8% | +36.8% | — |
| 3YCAGR | +59.7% | +38.3% | — |
| 5YCAGR | +32.4% | +19.0% | — |
| 10YCAGR | +15.2% | +1.2% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Diebold Nixdorf, Incorporated (DBD) valuation, health, and returns.
Diebold Nixdorf, Incorporated is estimated to be undervalued under our discounted cash flow framework. relative multiples indicate the stock is Cheap versus peers compared to industry peers. undervalued (implying +56.5% upside to DCF intrinsic value of $131.17)
Diebold Nixdorf, Incorporated has multiple valuation anchors: DCF Intrinsic Value: $131.17 | Peer Relative Fair Value: $157.27 | Wall Street Analyst Target: $100.00 (implying +19.3% upside). A convergence of these signals offers higher conviction.
Diebold Nixdorf, Incorporated displays fair financial health with a composite quality score of 46/100, supported by a Altman Z-Score of 1.7 (distress zone), Piotroski F-Score of 6/9, Return on Invested Capital (ROIC) of 14.0%.
Diebold Nixdorf, Incorporated returns capital via buybacks instead of dividends, carrying a 4.5% buyback yield and reducing outstanding shares by -1.1% in the last 12 months.
Diebold Nixdorf, Incorporated's current growth trajectory is Stable. The company achieved +1.5% 1Y revenue growth and +677.3% 1Y EPS growth, compared to its 3Y revenue CAGR of +3.2%.
Wall Street consensus is Buy based on 13 analysts, beating EPS expectations in 42% of recent quarters with a -1-quarter streak. The consensus price target represents a +19.3% change from current levels.
Investment risks for Diebold Nixdorf, Incorporated include: -22.5% 1-year max drawdown, elevated distress risk. Volatility risk is characterized by a beta of 1.24x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.